Network News

Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses Paris, June 23, 2026. The European Commission has approved Cenrifki (tolebrutinib) for the treatment of secondary progressive multiple sclerosis (SPMS) without relapses in the last two years. This follows the positive opinion by the European Medicines Agency’s Committee […]

‍ ZURICH, SWITZERLAND – June 10, 2026 — VERAXA Biotech AG, an emerging leader in designing novel cancer therapies, today announced that its previously announced business combination (“Business Combination”) with Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), a special purpose acquisition company sponsored by Cantor Fitzgerald & Co., Voyager Acquisition Sponsor Holdco LLC, and Odeon Capital Group LLC, was […]

The Heidelberg Faculty of Medicine at Heidelberg University presented the Anita and Friedrich Reutner Prize for Medical Research and the Hoffmann-Klose Prize for an outstanding Clinician Scientist project at this year’s Faculty Day – an event bringing together students, researchers, and teaching staff. The award recipients, Christine Zhang-Hagenlocher and Kristina Müller, are early-career physician-scientists From […]

For the first time in 14 years, there has been a change at the top of the hospital rankings, which are published annually by the MINQ Institute in collaboration with Stern. In its very first year of existence, the Heidelberg and Mannheim University Hospitals Consortium has taken first place. More information in German below: Zusammen […]

Finnish animal welfare legislation (Government Decree 1165/2023) effective as of January 1, 2024, requires establishments to apply “appropriate pain relief” in association with ear notching identification method of laboratory rodents(1). However, there is a lack of scientific evidence whether the benefits of applying analgesia outweigh the additional stress related to handling and drug administration. Our […]

Heidelberg, 15th of May 2026 – PEPperPRINT GmbH has successfully secured additional research and development funding from the innovation funding program “Invest BW” of the German state of Baden-Württemberg for the development of its new GlycoPlex platform, a high-throughput technology for disease-relevant glycopeptide analyses. The funded project, titled “GlycoPlex – High-Throughput Platform for Disease-Relevant Glycopeptide Analyses”, […]

Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector Paris, June 8, 2026. The European Commission has approved Sarclisa (isatuximab) subcutaneous (SC) in combination with standard-of-care regimens for the treatment of patients with multiple myeloma (MM) across all existing indications for Sarclisa intravenous (IV) formulation. Sarclisa is […]

New TREC pilot project explores how microbial life along rivers reflects environmental change and supports ecosystem health The European Molecular Biology Laboratory (EMBL) and regional partners, including the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg, have launched a pilot project in the Luxembourg area to investigate how microbial life within river […]

Joint press release from the medical faculties of Heidelberg and Mannheim The DFG is providing funding of around €5.8 million to support the continuation of Research Training Group 2727, ‘Checkpoints of Innate Immunity in Cancer and Tissue Damage (InCheck)’, led by the Faculty of Medicine in Mannheim. More information in German below: Wie funktionieren die […]